Drugs / RONOPTERIN
RONOPTERIN
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT02012582 | Nov 2009 → Jun 2012 | traumatic brain injury | veriNOS operations GmbH | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02794168 | Jun 2016 → Jun 2020 | traumatic brain injury | veriNOS operations GmbH | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02992236 Comparator | Aug 2015 → May 2016 | — | veriNOS operations GmbH | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RONOPTERIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL1230245 ↗ |
| Known as | 4-amino-tetrahydrobiopterin | “Safety and pharmacodynamics of 4-amino-tetrahydrobiopterin (VAS203)” PMID 24831445 ↗ Jul 2014 |
| Known as | Ronopterin, (6r)- | ChEMBL registry synonym — accepted as the source's own label CHEMBL1230245 ↗ |
| Known as | Ronopterina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1230245 ↗ |
| Known as | Ronopterine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1230245 ↗ |
| Known as | VAS203 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02794168 ↗ |
| Action | Inhibit | “Nitric Oxide Synthase inhibitor VAS203” NCT02012582 ↗ |
| Modality | Small molecule | “the antipterin VAS203” PMID 24831445 ↗ Jul 2014 |
| Route | Intravenous | “i.v. infusion” NCT02012582 ↗ |